YOUR VOICE IN CONGRESS
AAHF lobbies at the federal level
for legislation that increases consumers' health care freedom and access
to alternative therapies. We work to protect patient rights through legislation,
regulation and the courts.
Integrated Healthcare Policy Consortium
|AAHF Board Member and former Congressman Berkly
Bedell testifies on the Access to Medical Treatment Act in hearings
of the House Government Reform and Oversight Committee in February
1998. Seated behind him are Former AAHF Executive Director Candace
Campbell and health freedom activist Maury Silverman.
A National Working
Group of the Collaboration for Healthcare Renewal Foundation
Priorities for the 108th Congress
Our main priority for this Congress is passage
of the Access to Medical Treatment Act
HR 2085/SB 1410, however we are following
a number of other bills, amendments and proposed regulations. For instance
we are closely following the U.S. Food and Drug Administration’s efforts
to draft regulations on health claims for dietary supplements. We have
also filed comments on the agency’s proposed regulations regarding
the definition of disease.
FDA’s Ban On Dietary Supplements With Ephedrine Alkaloids
The Food and Drug Administration's
(FDA) action on December 30th is no surprise, we knew it was coming,
according to the AAHF's Washington
Lobbyist, Lee Bechtel. What is a surprise is that the FDA’s ruling
is broader than what has and is being portrayed in the press, and of
course by the FDA. The impact on future access to safe and effective
dietary supplements could be hugh, if and when the final regulation
is implemented and enforced.
The notice to consumers and dietary supplement manufacturers and distributors
on issuing a final rule, effective after a 60 day Congressional review
period, will prohibit the sale of any and all dietary supplements containing
ephedrine alkaloids, not just individual products containing ephedra.
The rule will not pertain to traditional Chinese herbal remedies or
to products like herbal teas. The FDA has sent 62 letters to firms
marketing dietary supplements containing ephedra and ephedrine alkaloids
alerting them of this future rule.
On the positive side, the FDA Commissioner is quoted
as saying that the agency is "going to issue a rule that clarifies and applies
a legal standard that has never been used before". This regulation
will be the first time ever that the standards in the dietary supplement
law, DSHEA, now ten years old, have been used to impose major restrictions
on the sale of dietary supplements.
Two Congressional Resolutions, House Resolution 435 and Senate Resolution
260, which support this FDA action, have already been introduced. When
Congress returns after January 20, 2004, it is very likely that these
will quickly be brought up for passage.
here to download the PDF (300k) that includes:
- FDA Press Release
- What The Ban Entails With Questions & Answers Concerning The
- The FDA Consumer Alert
- The Representative FDA Letter Sent To
- The List Of Manufacturers Receiving The Notice
our Legislative Action Center
for specific information about legislation we are following and more.
Read action alerts, track key votes, get information about Members of
Congress, find committee assignments, learn Capitol Hill basics, even
access a media guide, all searchable by state or zip code.
Plan to Advance Integrated Health Care
We have prepared the following National
Plan to Advance Integrated Health Care, in order to help focus the
health care debate in the coming millennium.
Center for Complementary and Alternative Medicine
AAHF led the effort to achieve passage of NCCAM,
which became law in October 1998.
House Commission on Complementary and Alternative Medicine Policy
As you may know, AAHF was instrumental in creating
the White House Commission on Complementary
and Alternative Medicine Policy several years ago, in an effort
to direct the Federal Government's attention to the advancement and
integration of CAM in the U.S. health care system.
National Policy Dialogue to Advance Integrated
Health Care: Finding Common Ground
October 31-November 3, 2001 Washington, D.C.
The National Policy Dialogue to Advance
Integrated Health Care: Finding
October 31-November 3, 2001, Washington, D.C.
On behalf of AAHF, Candace Campbell served on the Steering
Committee of the Integrated Healthcare Consortium that was established
to create this summit-style event. The Committee members believe that
the development of an integrated healthcare system demands the thoughtful,
collaborative attention of representatives from both conventional and
alternative/complementary disciplines. The purpose of the meeting was
to identify common ground as well as specific activities we could undertake
together to reach shared goals. Program